CROFT SHIFA HEALTH CENTRE — All Prescriptions & Medications — Page 2
Practice Code: P86014 | ROCHDALE, OL16 2UP
Showing results 51-100 of 579
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Senna | 779 | 42.4K | £957 | +29.4% ▲ |
| Gabapentin | 767 | 86.4K | £6.7K | -23.2% ▼ |
| Ezetimibe | 748 | 22.2K | £4.2K | +5.1% ▲ |
| Esomeprazole | 745 | 31.1K | £3.1K | +84.1% ▲ |
| Allopurinol | 744 | 26.7K | £648 | -27.8% ▼ |
| Furosemide | 724 | 25.4K | £621 | -51.3% ▼ |
| Alogliptin | 723 | 20.5K | £18.5K | +185.1% ▲ |
| Sitagliptin | 716 | 20.7K | £1.4K | +83.6% ▲ |
| Propranolol hydrochloride | 715 | 36.6K | £1.6K | -33.0% ▼ |
| Atenolol | 678 | 21.8K | £483 | +12.4% ▲ |
| Lercanidipine hydrochloride | 666 | 18.8K | £2.1K | +7.8% ▲ |
| 661 | 72.8K | £3.1K | +139.1% ▲ | |
| Canagliflozin | 655 | 19.8K | £24.6K | +356.2% ▲ |
| Lactulose | 635 | 301.2K | £2.8K | +92.9% ▲ |
| Budesonide | 617 | 671 | £14.7K | +13.8% ▲ |
| Candesartan cilexetil | 611 | 20.9K | £923 | -48.5% ▼ |
| Solifenacin | 593 | 18.9K | £699 | +24.3% ▲ |
| Quinine sulfate | 590 | 16.4K | £2.9K | +103.8% ▲ |
| Bisacodyl | 578 | 34.7K | £1.7K | +341.0% ▲ |
| Diazepam | 565 | 17.7K | £1.8K | +13.4% ▲ |
| Duloxetine hydrochloride | 562 | 18.9K | £1.9K | -11.6% ▼ |
| Betamethasone valerate | 502 | 42.4K | £4.1K | +30.4% ▲ |
| Prednisolone | 501 | 25.2K | £1.3K | -37.3% ▼ |
| Linagliptin | 499 | 14.9K | £16.9K | +21.8% ▲ |
| Empagliflozin | 487 | 14.3K | £17.8K | -22.2% ▼ |
| Semaglutide | 477 | 8,642 | £39.9K | +98.1% ▲ |
| Fluticasone furoate | 477 | 492 | £3.5K | +146.2% ▲ |
| Isophane insulin | 472 | 2,634 | £11.4K | +347.1% ▲ |
| 464 | 5,370 | £1.2K | +122.0% ▲ | |
| Finasteride | 460 | 15.7K | £5.2K | -29.8% ▼ |
| Zopiclone | 447 | 7,866 | £335 | -19.3% ▼ |
| Apixaban | 446 | 24.5K | £2.2K | -66.4% ▼ |
| Insulin aspart | 437 | 2,642 | £16.1K | +14.8% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 429 | 33.5K | £1.5K | +138.7% ▲ |
| Insulin glargine | 427 | 2,024 | £18.6K | +50.4% ▲ |
| Alendronic acid | 420 | 1,752 | £393 | -44.0% ▼ |
| Fluticasone propionate (Inhalation) | 415 | 446 | £9.3K | +7.2% ▲ |
| Mirabegron | 410 | 13.2K | £12.1K | +2.1% ▲ |
| Ranolazine | 408 | 25.8K | £4.6K | +140.1% ▲ |
| Zolpidem tartrate | 407 | 9,404 | £406 | +351.7% ▲ |
| Venlafaxine | 407 | 15.5K | £2.8K | -51.8% ▼ |
| Docusate sodium | 405 | 49.4K | £3.4K | +9.2% ▲ |
| Metformin hydrochloride/vildagliptin | 405 | 26.1K | £14.8K | +2,378.7% ▲ |
| Mometasone furoate | 399 | 437 | £3.4K | -0.6% vs avg |
| Olanzapine | 387 | 10.6K | £1.5K | +4.5% ▲ |
| Codeine phosphate | 386 | 26.4K | £910 | -46.3% ▼ |
| Prochlorperazine maleate | 381 | 21.9K | £1.1K | +88.5% ▲ |
| Betahistine hydrochloride | 378 | 30.1K | £1.1K | +58.3% ▲ |
| Carbocisteine | 377 | 55.1K | £3.1K | -29.4% ▼ |
| Promethazine hydrochloride | 374 | 21.7K | £2.0K | +4.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.